Bank of New York Mellon Corp Sells Stake in Merck & Co., Inc.
Bank of New York Mellon Corp has reduced its stake in Merck & Co., Inc. by selling 373,190 shares in the second quarter. This sale lowered their ownership to 18,340,173 shares, representing a 2% decrease.
The institutional investor's total holdings are valued at approximately $2,356,712,000, accounting for around 0.74% of Merck & Co., Inc.'s outstanding shares. The company has a market capitalization of $371.73 billion and a P/E ratio of 120.54.
Merck & Co., Inc. recently reported its quarterly earnings data on August 4th, exceeding analysts' estimates with ($0.13) earnings per share. The firm's revenue for the quarter was up 5.1% compared to the same period last year, reaching $16.61 billion.
The company has set a FY 2026 guidance at 2.660-2.760 EPS and its dividend payout ratio is currently 272.00%. Merck & Co., Inc.'s executive vice president Richard R. Deluca sold 11,699 shares of the stock on August 12th, while EVP David R. Maraldo sold 18,706 shares on August 5th.